Rapid Micro Biosystems (RPID) Net Margin (2020 - 2026)
Rapid Micro Biosystems (RPID) posted Net Margin of 178.39% for Q1 2026, down 61.05% sequentially from 110.77% in Q4 2025, and down 2207.0% YoY from 8.47% in Q1 2025.
Rapid Micro Biosystems (RPID) Net Margin (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems has reported Net Margin for 7 years, with the latest figure at 178.39% in Q1 2026.
- Quarterly Net Margin fell 2207.0% year-over-year to 178.39% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 145.81% (up 541.0% YoY) and the FY2025 annual result came in at 140.3%, up 2685.0% from the prior year.
- Net Margin eased to 178.39% in Q1 2026 per RPID's latest filing, from 110.77% in the prior quarter.
- Over five years, Net Margin peaked at 110.77% in Q4 2025 and troughed at 376.02% in Q4 2022.
- A 5-year average of 224.63% and a median of 190.06% in 2024 frame the typical range for Net Margin.
- The sharpest annual moves came in 2022 and 2023: Net Margin tumbled 11237 bps in 2022, then jumped 19972 bps in 2023.
- Over 5 years, Net Margin stood at 376.02% in 2022, then soared by 53 bps to 176.3% in 2023, then jumped by 33 bps to 117.62% in 2024, then rose by 6 bps to 110.77% in 2025, then tumbled by 61 bps to 178.39% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 178.39%, 110.77%, and 146.78% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 7.37% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 19.37% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 16.67% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 13.87% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 19.04% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 10.84% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 6.47% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 13.47% |
| 10 | Rapid Micro Biosystems | 80.50 Mn | 60.73 Mn | 1.21 Mn | -160.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -160.45% |
| Mar 31, 2026 | -178.39% |
| Dec 31, 2025 | -110.77% |
| Sep 30, 2025 | -146.78% |
| Jun 30, 2025 | -163.29% |
| Mar 31, 2025 | -156.32% |
| Dec 31, 2024 | -117.62% |
| Sep 30, 2024 | -148.91% |
| Jun 30, 2024 | -190.06% |
| Mar 31, 2024 | -237.43% |
| Dec 31, 2023 | -176.30% |
| Sep 30, 2023 | -217.93% |
| Jun 30, 2023 | -280.21% |
| Mar 31, 2023 | -275.81% |
| Dec 31, 2022 | -376.02% |
| Sep 30, 2022 | -344.78% |
| Jun 30, 2022 | -339.12% |
| Mar 31, 2022 | -358.89% |
| Dec 31, 2021 | -280.43% |
| Sep 30, 2021 | -365.68% |